Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-01-29 @ 8:24 AM
Study NCT ID:
NCT04068168
Status:
COMPLETED
Last Update Posted:
2025-11-17
First Post:
2019-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lung Cancer, Biliary Tract Cancer | View |
Keywords: